Skip to main navigation Skip to search Skip to main content

A multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma patients

  • Eudocia Q. Lee
  • , Thomas J. Kaley
  • , Dan G. Duda
  • , David Schiff
  • , Andrew B. Lassman
  • , Eric T. Wong
  • , Tom Mikkelsen
  • , Benjamin W. Purow
  • , Alona Muzikansky
  • , Marek Ancukiewicz
  • , Jason T. Huse
  • , Shakti Ramkissoon
  • , Jan Drappatz
  • , Andrew D. Norden
  • , Rameen Beroukhim
  • , Stephanie E. Weiss
  • , Brian M. Alexander
  • , Christine S. McCluskey
  • , Mary Gerard
  • , Katrina H. Smith
    • Rakesh K. Jain, Tracy T. Batchelor, Keith L. Ligon, Patrick Y. Wen
  • Dana-Farber Cancer Institute
  • Harvard University
  • Memorial Sloan-Kettering Cancer Center
  • Massachusetts General Hospital
  • University of Virginia
  • Columbia University
  • Beth Israel Deaconess Medical Center
  • Henry Ford Health System
  • University of Pittsburgh

Research output: Contribution to journal › Article › peer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma patients'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science